Prognostic impact of BTS (Baseline Tumor Size) on survival outcomes in patients with advanced Non-Small Cell Lung Cancer (NSCLC), treated with Pembrolizumab and Chemotherapy
Background: In patients with advanced NSCLC, the combination of immunotherapy and chemotherapy is one of the therapeutic possibilities. Recent data suggest that high BTS is a prognostic factor in patients treated with immunotherapy alone. The purpose of the study was to assess the impact of BTS on o...
Enregistré dans:
Auteurs principaux : | , , , , |
---|---|
Collectivités auteurs : | , |
Format : | Thèse ou mémoire |
Langue : | français anglais |
Titre complet : | Prognostic impact of BTS (Baseline Tumor Size) on survival outcomes in patients with advanced Non-Small Cell Lung Cancer (NSCLC), treated with Pembrolizumab and Chemotherapy / Thibault Bellon; sous la direction de Renan Liberge |
Publié : |
2022 |
Description matérielle : | 1 vol. (45 p.) |
Note de thèse : | Thèse d'exercice : Médecine. Radiologie et imagerie médicale : Nantes : 2022 |
Contenu : | La thèse contient 1 article p.30 |
Sujets : | |
Documents associés : | Reproduit comme:
Prognostic impact of BTS (Baseline Tumor Size) on survival outcomes in patients with advanced Non-Small Cell Lung Cancer (NSCLC), treated with Pembrolizumab and Chemotherapy |
BU Santé
| Cote | Prêt | Statut |
---|---|---|---|
Magasin - S'adresser à l'Accueil | 22 NANT 198M | Empruntable | Disponible |